Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Expert Opinion on Therapeutic Patents|March 9, 2010
P2X purinergic receptor ligands: recently patented compoundsHendra Gunosewoyo, Michael Kassiou
International Journal of Molecular Sciences|March 29, 2023
Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug TargetsShahinda S R Alsayed, Hendra Gunosewoyo
Life Sciences|June 2, 2018
Efflux transporters and tight junction expression changes in human gastrointestinal cell lines cultured in defined medium vs serum supplemented mediumAparna Warrier, Hendra Gunosewoyo, Andrew Crowe
International Journal of Molecular Sciences|November 27, 2024
Combating Tuberculosis via Restoring the Host Immune Capacity by Targeting <i>M. tb</i> Kinases and PhosphatasesShahinda S R Alsayed, Hendra Gunosewoyo
Current Medicinal Chemistry|June 23, 2007
Molecular probes for P2X7 receptor studiesHendra Gunosewoyo, Mark J Coster, Michael Kassiou
Future Medicinal Chemistry|February 9, 2017
Kinase targets in CNS drug discoveryHendra Gunosewoyo, Lifang Yu, Lenka Munoz, et al.
Current Medicinal Chemistry|July 14, 2023
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021Caitlin L Duncan, Hendra Gunosewoyo, Mauro Mocerino, et al.
Bioorganic & Medicinal Chemistry|June 23, 2009
Purinergic P2X(7) receptor antagonists: Chemistry and fundamentals of biological screeningHendra Gunosewoyo, Mark J Coster, Maxwell R Bennett, et al.
ACS Medicinal Chemistry Letters|May 4, 2013
From α4β2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational DesignLi-Fang Yu, Han-Kun Zhang, Hendra Gunosewoyo, et al.
Chemical Biology & Drug Design|February 27, 2021
Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivativesShahinda S R Alsayed, Shichun Lun, Alan Payne, et al.
Pageof 5